Baker Brothers Advisors - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.9%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q1 2021$2,684,000
-18.8%
114,7350.0%0.01%0.0%
Q4 2020$3,304,000
+22.3%
114,735
-13.9%
0.01%
+9.1%
Q3 2020$2,701,000
-32.6%
133,3330.0%0.01%
-38.9%
Q2 2020$4,007,000
-4.4%
133,3330.0%0.02%
-30.8%
Q1 2020$4,191,000
-33.3%
133,3330.0%0.03%
-21.2%
Q4 2019$6,281,000
+629.5%
133,3330.0%0.03%
+450.0%
Q3 2019$861,000
-47.4%
133,3330.0%0.01%
-45.5%
Q2 2019$1,637,000
-9.4%
133,3330.0%0.01%
-8.3%
Q1 2019$1,807,000
+237.8%
133,3330.0%0.01%
+200.0%
Q4 2018$535,000
-40.4%
133,3330.0%0.00%
-33.3%
Q3 2018$897,000133,3330.01%
Other shareholders

There were no reported owners of CONSTELLATION PHARMCETICLS I in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CONSTELLATION PHARMCETICLS I shareholders